Eliminating catheter-related bloodstream infections in the intensive care unit*

Sean M. Berenholtz(Pall Corporation (United States)), Peter J. Pronovost(Pall Corporation (United States)), Pamela A. Lipsett(Pall Corporation (United States)), Deborah B. Hobson(Pall Corporation (United States)), Karen Earsing(Pall Corporation (United States)), Jason E. Farley(Pall Corporation (United States)), Shelley Milanovich(Pall Corporation (United States)), Elizabeth Garrett‐Mayer(Pall Corporation (United States)), Bradford D. Winters(Pall Corporation (United States)), Haya R. Rubin(Pall Corporation (United States)), Todd Dorman(Pall Corporation (United States)), Trish M. Perl(Pall Corporation (United States))
Critical Care Medicine
October 1, 2004
Cited by 993

Abstract

OBJECTIVE: To determine whether a multifaceted systems intervention would eliminate catheter-related bloodstream infections (CR-BSIs). DESIGN: Prospective cohort study in a surgical intensive care unit (ICU) with a concurrent control ICU. SETTING: The Johns Hopkins Hospital. PATIENTS: All patients with a central venous catheter in the ICU. INTERVENTION: To eliminate CR-BSIs, a quality improvement team implemented five interventions: educating the staff; creating a catheter insertion cart; asking providers daily whether catheters could be removed; implementing a checklist to ensure adherence to evidence-based guidelines for preventing CR-BSIs; and empowering nurses to stop the catheter insertion procedure if a violation of the guidelines was observed. MEASUREMENT: The primary outcome variable was the rate of CR-BSIs per 1,000 catheter days from January 1, 1998, through December 31, 2002. Secondary outcome variables included adherence to evidence-based infection control guidelines during catheter insertion. MAIN RESULTS: Before the intervention, we found that physicians followed infection control guidelines during 62% of the procedures. During the intervention time period, the CR-BSI rate in the study ICU decreased from 11.3/1,000 catheter days in the first quarter of 1998 to 0/1,000 catheter days in the fourth quarter of 2002. The CR-BSI rate in the control ICU was 5.7/1,000 catheter days in the first quarter of 1998 and 1.6/1,000 catheter days in the fourth quarter of 2002 (p = .56). We estimate that these interventions may have prevented 43 CR-BSIs, eight deaths, and 1,945,922 dollars in additional costs per year in the study ICU. CONCLUSIONS: Multifaceted interventions that helped to ensure adherence with evidence-based infection control guidelines nearly eliminated CR-BSIs in our surgical ICU.


Related Papers

No related papers found

Powered by citation graph analysis